SCHEMBL9970655

SCHEMBL9970655

Nc1c(-c2ccc(C(=O)O)cc2F)ccc2cc(O)ccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 5/20 0.41
ESR2 Q92731 4/20 0.41
RARB P10826 2/20 0.38
RARA P10276 1/20 0.38
RARG P13631 1/20 0.38
HSD17B1 P14061 1/20 0.38
HSD17B2 P37059 1/20 0.38
AXL P30530 1/20 0.38
CSNK2A2 P19784 1/20 0.37
CSNK2B P67870 1/20 0.37
CSNK2A1 P68400 1/20 0.37
CSNK2A3 Q8NEV1 1/20 0.37
RAB9A P51151 2/20 0.37
AKR1B1 P15121 1/20 0.37
MEN1 O00255 1/20 0.37
NPC1 O15118 1/20 0.37
KMT2A Q03164 1/20 0.37
LMNA P02545 1/20 0.37
MAPK1 P28482 1/20 0.37
HTT P42858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9938893 0.81 ESR1 (0.45) ESR1ESR2RARBHSD17B1HSD17B2
SCHEMBL9938410 0.77 ESR2 (0.71) ESR1ESR2RARBHSD17B1HSD17B2
SCHEMBL14156932 0.77 ESR1 (0.55) ESR1ESR2RARBHSD17B1HSD17B2
SCHEMBL14213193 0.75 LMNA (0.57) RARBAXLRAB9AKMT2ALMNA
SCHEMBL9939166 0.73 MIF (0.49) ESR1ESR2HSD17B1HSD17B2RAB9A
SCHEMBL1289643 0.73 HSD17B14 (0.49) ESR1ESR2RARBRARGCSNK2A1
SCHEMBL9938098 0.72 L3MBTL1 (0.45) ESR1ESR2AXLCSNK2A1RAB9A
SCHEMBL29038427 0.70 KMT2A (0.51) RARBAXLRAB9AMEN1KMT2A
SCHEMBL9939322 0.70 ESR1 (0.44) ESR1ESR2RARBRARARARG
SCHEMBL1289591 0.70 ESR1 (0.43) ESR1ESR2RARBRARARARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012083171-A1 NOVEL SUBSTITUTED BICYCLIC AROMATIC COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS N30 PHARMACEUTICALS, LLC (US) 2012-06-21 WO disclosed